Literature DB >> 9207624

Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium.

M M Marijianowski1, P Teeling, A E Becker.   

Abstract

OBJECTIVES: This study was specifically designed to evaluate whether noninfarcted hypertrophic myocardium in patients with end-stage heart failure after myocardial infarction (MI) is associated with an increase in interstitial fibrous tissue.
BACKGROUND: Postinfarction remodeling consists of complex alterations that involve both infarcted and noninfarcted myocardium. The question arises whether ventricular dysfunction is due to physical events, such as inadequate myocardial hypertrophy to compensate for increased tangential wall stress, or is caused by the development of progressive interstitial fibrosis in noninfarcted myocardium.
METHODS: Fifteen hearts were obtained as cardiac explants (n = 13) or at autopsy (n = 2) from patients with end-stage coronary artery disease. Sixteen normal hearts served as reference hearts. Samples were taken from the left ventricular (LV) wall that contained the infarcted area, the border area and noninfarcted myocardium remote from scar areas. Collagen was quantified biochemically and microdensitophotometrically. Collagen type I and III ratios were analyzed by using the cyanogen bromide method and immunohistochemical staining, followed by microdensitophotometric quantification.
RESULTS: In noninfarcted myocardium remote from the scar areas, total collagen levels and collagen type I/III ratios did not differ statistically from those in reference hearts. These observations contrasted with high total collagen content and high collagen type I/III ratios in scar and border areas.
CONCLUSIONS: Remodeling of LV myocardium after MI in patients with end-stage heart failure is not necessarily associated with interstitial fibrosis in noninfarcted hypertrophic myocardium remote from scar areas. This finding raises questions regarding therapeutic interventions designed to prevent or retard the development of interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207624     DOI: 10.1016/s0735-1097(97)00100-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

2.  Interstitial fibrosis in the dilated non-ischaemic myocardium.

Authors:  A Brooks; V Schinde; A C Bateman; P J Gallagher
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 3.  Physiological Implications of Myocardial Scar Structure.

Authors:  William J Richardson; Samantha A Clarke; T Alexander Quinn; Jeffrey W Holmes
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

4.  Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model.

Authors:  David Lopez; Jonathan A Pan; Peter M Pollak; Samantha Clarke; Christopher M Kramer; Mark Yeager; Michael Salerno
Journal:  NMR Biomed       Date:  2017-02-06       Impact factor: 4.044

Review 5.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

Authors:  Nathan Mewton; Chia Ying Liu; Pierre Croisille; David Bluemke; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

6.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

7.  Hyperoxia and transforming growth factor β1 signaling in the post-ischemic mouse heart.

Authors:  Yuanjing Li; Ming Cai; Qinghua Sun; Zhenguo Liu; Arturo J Cardounel; Harold M Swartz; Guanglong He
Journal:  Life Sci       Date:  2013-01-24       Impact factor: 5.037

8.  The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model.

Authors:  Jugajyoti Baruah; Ryan Hitzman; Jane Zhang; Suhnrita Chaudhuri; Victoria Mastej; Kishore K Wary
Journal:  J Biol Chem       Date:  2017-10-25       Impact factor: 5.157

9.  A Multidisciplinary Assessment of Remote Myocardial Fibrosis After Reperfused Myocardial Infarction in Swine and Patients.

Authors:  Arantxa Hervas; Amparo Ruiz-Sauri; Jose Gavara; Jose V Monmeneu; Elena de Dios; Cesar Rios-Navarro; Nerea Perez-Sole; Itziar Perez; Daniel Monleon; Jose M Morales; Gema Minana; Julio Nunez; Clara Bonanad; Ana Diaz; Jose M Vila; Francisco J Chorro; Vicente Bodi
Journal:  J Cardiovasc Transl Res       Date:  2016-06-01       Impact factor: 4.132

Review 10.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.